Pre-therapy Somatostatin Receptor-Based Heterogeneity Predicts Overall Survival in Pancreatic Neuroendocrine Tumor Patients Undergoing Peptide Receptor Radionuclide Therapy

Molecular Imaging and Biology : MIB : the Official Publication of the Academy of Molecular Imaging
Rudolf A WernerRalph A Bundschuh

Abstract

Early identification of aggressive disease could improve decision support in pancreatic neuroendocrine tumor (pNET) patients prior to peptide receptor radionuclide therapy (PRRT). The prognostic value of intratumoral textural features (TF) determined by baseline somatostatin receptor (SSTR)-positron emission tomography (PET) before PRRT was analyzed. Thirty-one patients with G1/G2 pNET were enrolled (G2, n = 23/31). Prior to PRRT with [177Lu]DOTATATE (mean, 3.6 cycles), baseline SSTR-PET computed tomography was performed. By segmentation of 162 (median per patient, 5) metastases, intratumoral TF were computed. The impact of conventional PET parameters (SUVmean/max), imaging-based TF, and clinical parameters (Ki67, CgA) for prediction of both progression-free survival (PFS) and overall survival (OS) after PRRT were evaluated. Within a median follow-up of 3.7 years, tumor progression was detected in 21 patients (median, 1.5 years) and 13/31 deceased (median, 1.9 years). In ROC analysis, the TF entropy, reflecting derangement on a voxel-by-voxel level, demonstrated predictive capability for OS (cutoff = 6.7, AUC = 0.71, p = 0.02). Of note, increasing entropy could predict a longer survival (> 6.7, OS = 2.5 years, 17/31), whereas l...Continue Reading

References

Apr 20, 2002·Seminars in Nuclear Medicine·Dik J Kwekkeboom, Eric P Krenning
Jan 1, 1950·Cancer·W J YOUDEN
Dec 21, 2005·Annals of Oncology : Official Journal of the European Society for Medical Oncology·F PanzutoG Delle Fave
Jan 27, 2006·European Journal of Nuclear Medicine and Molecular Imaging·Sophia KoukourakiAntonia Dimitrakopoulou-Strauss
Aug 25, 2006·Breast Cancer : the Journal of the Japanese Breast Cancer Society·Kansei KomakiAkira Tangoku
May 1, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Dik J KwekkeboomEric P Krenning
Nov 11, 2008·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Anne CouvelardPhilippe Ruszniewski
Dec 23, 2008·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·E A EisenhauerJ Verweij
Aug 20, 2009·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Michael GabrielIrene J Virgolini
Sep 21, 2010·European Journal of Nuclear Medicine and Molecular Imaging·Samer EzziddinHojjat Ahmadzadehfar
Oct 29, 2010·Nature·Shinichi YachidaChristine A Iacobuzio-Donahue
Feb 11, 2011·The New England Journal of Medicine·Eric RaymondPhilippe Ruszniewski
Feb 16, 2011·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Florent TixierDimitris Visvikis
Feb 26, 2011·Endocrinology and Metabolism Clinics of North America·Ben LawrenceIrvin M Modlin
May 12, 2011·European Journal of Nuclear Medicine and Molecular Imaging·Mathieu HattCatherine Cheze-le Rest
Apr 20, 2012·Nature Reviews. Cancer·Andriy MarusykKornelia Polyak
Apr 25, 2012·Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract·C E CauleyK D Lillemoe
Feb 8, 2013·European Journal of Nuclear Medicine and Molecular Imaging·L BodeiJohn J Zaknun
Feb 8, 2014·European Journal of Nuclear Medicine and Molecular Imaging·Samer EzziddinAmir Sabet
Apr 23, 2014·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Ralph A BundschuhMarkus Essler
Jun 4, 2014·Nature Communications·Hugo J W L AertsPhilippe Lambin
Oct 17, 2014·Molecular Imaging and Biology : MIB : the Official Publication of the Academy of Molecular Imaging·C KratochwilF L Giesel
Dec 17, 2014·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Mathieu HattDimitris Visvikis
Aug 26, 2015·Frontiers of Hormone Research·Merav FraenkelGerlof D Valk
Oct 5, 2015·Cancer Metastasis Reviews·Rocio Garcia-CarboneroUNKNOWN Spanish Cooperative Group of Neuroendocrine Tumors (GETNE)
Dec 26, 2015·Lancet·James C YaoUNKNOWN RAD001 in Advanced Neuroendocrine Tumours, Fourth Trial (RADIANT-4) Study Group
Feb 14, 2016·European Journal of Nuclear Medicine and Molecular Imaging·Seung Hyup HyunJoon Young Choi
Apr 16, 2016·Endocrine-related Cancer·J R StrosbergE K Bergsland
May 11, 2016·European Journal of Nuclear Medicine and Molecular Imaging·Hendrik BergsmaDik J Kwekkeboom
Nov 5, 2016·European Journal of Nuclear Medicine and Molecular Imaging·Ivayla ApostolovaThomas Kalinski
Sep 11, 2016·European Journal of Nuclear Medicine and Molecular Imaging·Masatoyo NakajoTakashi Yoshiura
Nov 1, 2016·European Journal of Nuclear Medicine and Molecular Imaging·Maddalena SansoviniGiovanni Paganelli
Oct 16, 2016·Molecular Imaging and Biology : MIB : the Official Publication of the Academy of Molecular Imaging·Christoph WetzHolger Amthauer
Dec 10, 2016·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Xin LiMartin G Pomper
Jan 12, 2017·The New England Journal of Medicine·Jonathan StrosbergUNKNOWN NETTER-1 Trial Investigators
Apr 22, 2017·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Tessa BrabanderDik J Kwekkeboom

❮ Previous
Next ❯

Citations

Sep 27, 2020·Reviews in Endocrine & Metabolic Disorders·M AlbertelliUNKNOWN NIKE
Aug 16, 2019·European Journal of Nuclear Medicine and Molecular Imaging·Josephine GrafVikas Prasad
Aug 12, 2020·Cancer Imaging : the Official Publication of the International Cancer Imaging Society·Daphne M V HuizingMarcel P M Stokkel
Oct 17, 2018·International Journal of Molecular Sciences·Julia WanekTobias Kiesslich
Jan 15, 2020·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Kyle CurrentKatharina Lueckerath
Dec 11, 2020·Diagnostics·Diletta CalabròValentina Ambrosini
Mar 7, 2021·Diagnostics·Manuel Piñeiro-FielPablo Aguiar
Mar 16, 2021·Current Oncology Reports·N S MinczelesT Brabander
Apr 10, 2021·European Journal of Nuclear Medicine and Molecular Imaging·C BezziM Picchio
Apr 28, 2021·European Journal of Nuclear Medicine and Molecular Imaging·Wolfgang RollKambiz Rahbar
Jun 1, 2021·PET Clinics·Rebecca K S WongPatrick Veit-Haibach
Feb 14, 2021·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Claudia OrtegaUr Metser

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adenoma, Islet Cell

Islet Cell Adenoma arises in the islet cells, which are insulin producing cells of the pancreas. These tumors can be either malignant or benign. Discover the latest research on Islet Cell Adenoma here.

Carcinoma, Islet Cell (Keystone)

Islet Cell Carcinoma or Pancreatic Neuroendocrine Tumours arise in the hormone producing cells of the pancreas. These tumors can be either malignant or benign. Discover the latest research on islet cell carcinoma in this feed.

Carcinoma, Islet Cell

Islet Cell Carcinoma or Pancreatic Neuroendocrine Tumours arises in the hormone producing cells of the pancreas. These tumors can be either malignant or benign. Discover the latest research on Islet Cell Carcinoma here.